Paramignya trimera
Paramignya trimera · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Paramignya trimera is a botanical species that has garnered scientific interest due to its complex phytochemical profile. Research into its stem has identified key bioactive compounds, including luvangetin, various coumarins, and 8-geranyl-7-hydroxycoumarin. Studies utilizing an EtOH(aq) extract have specifically highlighted the presence of 6-(2-Hydroxyethyl)-2,2-dimethyl-2H-1-benzopyran. These chemical constituents are currently being investigated for their therapeutic potential against serious medical conditions. Most notably, the plant shows significant promise in research targeting cancer, particularly in the treatment of liver cancer.
- Synonyms
- Atalantia Trimera · Severinia Trimera
- Common names
- Not available
- Family
- Rutaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Stem
Classification
Synonyms
Paramignya trimera is a botanical species that is frequently identified through various scientific designations in taxonomic literature. Due to shifting classifications, this plant is officially recognized by the synonym Atalantia trimera. Researchers also refer to the same species under the alternative name Severinia trimera. Understanding these overlapping nomenclatures is essential for maintaining accuracy in plant databases and field studies. Consequently, recognizing these synonyms ensures that the biological identity of the plant remains consistent across different academic contexts.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Paramignya trimera is a distinctive botanical specimen belonging to the kingdom Plantae. Within this vast realm, the plant is classified under the class Equisetopsida. It further resides in the order Sapindales, showcasing its specific evolutionary lineage. As a member of the family Rutaceae, it shares characteristics with many other citrus-related species. Ultimately, this plant is identified by its unique designation within the genus Paramignya.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Rutaceae |
| Genus | Paramignya |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Paramignya trimera is a distinctive plant species primarily found within the diverse ecosystems of the Asia-Tropical region. Its natural range extends significantly through the lush landscapes of Indo-China, where it thrives in specific environmental niches. Within these territories, Vietnam serves as a key area for its distribution and growth. This geographic footprint highlights the plant's reliance on the warm, humid climates characteristic of Southeast Asian habitats. Understanding these specific locations is essential for researchers studying its ecological role and conservation needs.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Paramignya trimera is a distinctive plant characterized by its shrub-like growth form. It follows an obligatory climbing habit, meaning it relies on external structures to ascend and support its weight. Depending on its environment, the plant can reach a minimum height of 1 meter. Ultimately, this climbing species can extend upward to a maximum height of 10 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Paramignya trimera is a medicinal plant from the Rutaceae family that has traditionally been used to treat cancer and liver diseases. Recent chemical investigations into its stems have successfully isolated several key coumarin constituents. Specifically, researchers have identified that Paramignya trimera contains 8-geranyl-7-hydroxycoumarin, which contributes to its complex chemical profile. The plant also contains luvangetin, a compound that plays a role in inhibiting nitric oxide and PGE2 production. Furthermore, the presence of ostruthin in Paramignya trimera suggests significant potential for developing new anti-neuroinflammatory agents.
Conditions
Paramignya trimera demonstrates significant anti-proliferative capacity against several specific cancer cell lines. The plant extract effectively treats A2780 ovarian cancer cells and A431 skin cancer cells. It also shows therapeutic potential against BE2-C neuroblastoma. Furthermore, the plant is effective in treating Du145 prostate cancer cells. Finally, Paramignya trimera provides treatment benefits against H460 lung cancer cells.
Preparations
Paramignya trimera is prepared as an EtOH(aq) extract to facilitate the isolation of its chemical constituents. Researchers utilized this specific aqueous ethanol extraction method on the stems of the plant to obtain various compounds. From this extract, several new dimeric coumarins known as paratrimerins J-Y were successfully isolated. The extraction process allowed for the subsequent structural elucidation of these molecules using advanced spectroscopic techniques. This methodical preparation of Paramignya trimera serves as the foundation for studying its potential medicinal properties.
Parts used
Paramignya trimera serves as a significant source of diverse chemical compounds, particularly within its stem tissues. Recent studies have successfully isolated a series of new dimeric coumarins, known as paratrimerins J-Y, from the ethanol extract of these stems. Through advanced spectroscopic analysis, researchers were able to elucidate the complex structures and absolute configurations of these unique metabolites. The structural diversity found in these compounds highlights the intricate biosynthetic processes occurring within the plant. Furthermore, the medicinal potential of these stem-derived dimers is promising, as certain constituents have demonstrated notable cytotoxicity against various human cancer cell lines.